Test results on COVID-19 vaccine trials developed by Oxford University and supported by AstraZeneca Plc have shown positive results. Researchers have found in their experimental COVID-19 vaccine that it has produced double immunity in people between the ages of 18 and 55, i.e., body antibodies and also strengthened the immune system. Oxford designed the vaccine in order to prevent disease and reduce transmission. Dr. Adrian Hill, director of the Jenner Institute of Oxford University, said “this vaccine triggers both arms of the immune system”.
Friday, September 24, 2021